Latest news
Loading news…
Gyroscope Therapeutics is a clinical-stage gene therapy company focused on developing therapies and treating diseases of the eye.
Gyroscope Therapeutics was acquired by Novartis in 2021 for $2B.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
1
Monthly Visits
Available in Pro Contacts
94
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- Stevenage, Herefordshire, United Kingdom
Acquisitions by Gyroscope Therapeutics
Loading columns…
0 of 0Show
Page 1 / 1
Key People at Gyroscope Therapeutics
Senior Director, Associate General Counsel
Professor of Nephrology, Newcastle, Academic Founder
Chief Executive Officer
Professor of Ophthalmology, University of Southampton, Academic Founder
Academic Founder
94
professional contacts at Gyroscope Therapeutics
Contact execs at Gyroscope Therapeutics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Gyroscope Therapeutics
Loading news…
FAQs about Gyroscope Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.